Jessica Tang, PhD

Title(s)Postdoctoral Scholar, Dermatology
SchoolSchool of Medicine
Address2340 Sutter Street
San Francisco CA 94115
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Santa Barbara, Santa Barbara, CABA06/2011Biology
    Indiana University, Bloomington, INMS05/2013Microbiology
    Indiana University, Bloomington, INPhD06/2018Physiology
    Collapse Awards and Honors
    Indiana Clinical and Translational Sciences Institute2013  - 2015Pre-doctoral training grant
    Indiana University School of Medicine2014Paul M. Harmon Award
    Indiana University School of Medicine2016  - 2018Doane and Eunice Dahl Wright Memorial Fellowship

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clin Cancer Res. An effective epigenetic-PARP inhibitor combination therapy for ovarian and breast cancers independent of BRCA-mutations. 2018; 13(24):3163-3175. Pulliam N., Fang F., Özes A., Tang J., Adewuyi A., Keer H., Lyons J., Baylin S., Matei D., Nakshatri H., Rassool F., Miller K., Nephew KP.
    2. Oncogene. Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity. 2018; 26(37):3589-3600. Özes A, Pulliam N., Tang J., Yilm az Ö., Ertosun G, Matei D, Özes O., Nephew KP.
    3. Epigenetic targeting of adipocytes inhibits high-grade serous ovarian cancer cell migration and invasion. Molecular Cancer Research. 2018; 8(16):1226-1240 . Tang J, Pulliam N., Özes A, Buechlein A., Ding N., Keer H., Rusch D., O’Hagan H., Stack M., Nephew KP.
    4. In: Xiaoting Zhang, editor. Cancer Drug Discovery, Development. New York: Humana Press. Estrogen receptor regulation of microRNAs in breast cancer. 2018. Pulliam N., Tang J., Nephew KP.
    5. Integr Cancer Sci and Therap. Delphinidin and cyanidin exhibit antiproliferative and apoptotic effects in MCF7 human breast cancer cells. 2015; 1(2):82-86. Tang J, Oroudjev E, Wilson L, Ayoub G.
    6. Clin Cancer Res. The novel, small molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer. 2014; 24(20):6504-6516. Fang F*, Munck J*, Tang J*, Taverna P, Wang Y, Miller DF, Pilrose J, Choy G, Azab M, Pawelczak KS, VanderVere-Carozza P, Wagner M, Lyons J, Matei D, Turchi JJ, and Nephew KP (*Equal contribution).
    7. In: Verma M, editor. Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis. New York: Humana Press. Global DNA methylation profiling technologies and the ovarian cancer methylome. 2014. Tang J, Fang F, Miller D, Pilrose J, Matei D, Huang T, Nephew KP.
    8. J Med Food. Cytotoxic effects of bilberry extract on MCF7-GFP-tubulin breast cancer cells. 2010; 2(13):278-85. Nguyen V, Tang J, Oroudjev E, Lee CJ, Marasigan C, Wilson L, Ayoub G.
    9. Phytother Res. Hesperidin suppressed proliferations of both Human breast cancer and androgen-dependent prostate cancer cells. 2010; 4(24):632. Lee CJ, Wilson L, Jordan MA, Nguyen V, Tang J, Smiyun G.